alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### **CHAPTER 95—ELIMINATE, NEUTRALIZE, AND DISRUPT WILDLIFE TRAFFICKING**

Sec.
7601.
Definitions.

#### SUBCHAPTER I—PURPOSES AND POLICY

7611.
Purposes.
7612.
Statement of United States policy.

#### SUBCHAPTER II—REPORT ON MAJOR WILDLIFE TRAFFICKING COUNTRIES

7621.
Report.

#### SUBCHAPTER III—FRAMEWORK FOR INTERAGENCY RESPONSE

7631.
Presidential Task Force on Wildlife Trafficking.

#### SUBCHAPTER IV—PROGRAMS TO ADDRESS THE ESCALATING WILDLIFE TRAFFICKING CRISIS

7641.
Anti-poaching programs.
7642.
Anti-trafficking programs.
7643.
Engagement of United States diplomatic missions.
7644.
Community conservation.
Progenics Pharmaceuticals, Inc.

777 Old Saw Mill River Road

Tarrytown, New York 10591

Fax: (914) 789-2817

(914) 789-2800

www.progenics.com  Contact:
Melissa Downs

Investor Relations

(914) 789-2801

mdowns@progenics.com
 TARRYTOWN, NY, April 7, 2015 – Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that its partner, FUJIFILM RI Pharma Co. Ltd. (Fuji), has dosed the first patient in its early Phase 2 trial of 1404 in Japan in newly-diagnosed prostate cancer patients with lymph node and/or bone metastases or at high risk for metastatic disease. 1404 is a targeted small molecule designed to visualize prostate cancer by targeting prostate specific membrane antigen (PSMA).
 
  
 high risk for metastatic prostate cancer, using
 
 
 TM ® www.progenics.com
   www.progenics.com ®
 
 
 Editor's Note
 
 www.progenics.com
 
 www.relistor.com
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Equal Employment Opportunity Commission

# AGENCY HOLDING THE MEETING:

 Equal Employment Opportunity Commission.

# DATE AND TIME:

Tuesday, March 15, 2011, 1 p.m. Eastern Time.

# PLACE:

Commission Meeting Room on the First Floor of the EEOC Office Building, 131 “M” Street, NE., Washington, DC 20507.

# STATUS:

The meeting will be open to the public.

# MATTERS TO BE CONSIDERED:

## Open Session

1. Announcement of Notation Votes, and

2. Employment of People with Mental Disabilities.

# Note:

                         In accordance with the Sunshine Act, the meeting will be open to public observation of the Commission's deliberations and voting. Seating is limited and it is suggested that visitors arrive 30 minutes before the meeting in order to be processed through security and escorted to the meeting room. (In addition to publishing notices on EEOC Commission meetings in the                         **Federal Register**                        , the Commission also provides information about Commission meetings on its Web site,                         *http://www.eeoc.gov.,*                         and provides a recorded announcement a week in advance on future Commission sessions.)                    

Please telephone (202) 663-7100 (voice) and (202) 663-4074 (TTY) at any time for information on these meetings. The EEOC provides sign language interpretation and Communication Access Realtime Translation (CART) services at Commission meetings for individuals who are deaf or hard of hearing. Requests for other reasonable accommodations may be made by using the voice and TTY numbers listed above.

# CONTACT PERSON FOR MORE INFORMATION:

Stephen Llewellyn, Executive Officer on (202) 663-4070.

Dated: March 4, 2011.

Stephen Llewellyn,

Executive Officer, Executive Secretariat.

[FR Doc. 2011-5361 Filed 3-4-11; 4:15 pm]

BILLING CODE 6570-01-P
From: Jordan, Ronald
To: jlapcev@firstenergycorp.com
Cc: Thomas Finseth ; Schroeder, Cuc ; Flanders, Phillip Subject: Available for a short call on Monday?
Date: Thursday, May 29, 2014 12:20:28 PM

Joe,
Are you available for a short call on Monday? We have just a few more questions, including these listed below:

1. Comparing the data you provided on 5/2/2014 and 5/13/2014, we observed apparent data entry errors. Please specify which values for mercury Chem Precip Effluent are correct.

Date 5/2/2014 dataset (Hg, ng/L) 5/13/2014 dataset (Hg, ng/L) 12/20/2011 122 12.2 1/3/2012 424 42.4 2/2/2012 144 14.4 2/21/2012 170 17

2. What is the cause for elevated mercury concentrations for Chem Precip Effluent on the following dates?

a. 2/28/2012 (1520 ng/L) b. 3/13/2012 (1160 ng/L)

c. 3/20/2012 (1710 ng/L) d. 3/27/2012 (1320 ng/L)

e. 4/3/2012 (3400 ng/L) f. 6/5/2012 (830 ng/L)

3. We noticed dates for Method 245.1 (mercury) data and Method 200.8 (arsenic) data changed between your original spreadsheet provided 2/20/2014 and the updated spreadsheets provided 5/2/2014 and 5/13/2014. Specifically, the 2/20/2014 spreadsheet shows the 245.1 and 200.8 data on 12/18/12, 1/4/13, and 1/8/13; the 5/2/2014 spreadsheet shows these data on 11/29/12, 12/19/12, and 12/21/12. Which dates are correct?
### SUBCHAPTER II—SPORTSMEN'S ACCESS TO FEDERAL LAND
§ 27.5 Review. ( a ) Within 30 calendar days of a finding of a lack of jurisdiction, a final determination on the merits, or corrective action ordered by the Director, the Complainant or the FBI may request review by the Deputy Attorney General of that determination or order. The Deputy Attorney General shall set aside or modify the Director's actions, findings, or conclusions found to be arbitrary, capricious, and abuse of discretion, or otherwise not in accordance with law; obtained without procedures required by law, rule, or regulation having been followed; or unsupported by substantial evidence. The Deputy Attorney General has full discretion to review and modify corrective action ordered by the Director, provided, however that if the Deputy Attorney General upholds a finding that there has been a reprisal, then the Deputy Attorney General shall order appropriate corrective action.
( b ) The parties may not file an interlocutory appeal to the Deputy Attorney General from a procedural ruling made by the Director during proceedings pursuant to § 27.4 of this part. The Deputy Attorney General has full discretion to review such rulings by the Director during the course of reviewing an appeal of the Director's finding of a lack of jurisdiction, final determination, or corrective action order brought under paragraph (a) of this section.
( c ) In carrying out the functions set forth in this section, the Deputy Attorney General may issue written directives or orders to the parties as necessary to ensure the efficient and fair administration and management of the review process.
[89 FR 7286, Feb. 2, 2024]
### §1725a. Direct hire authority

(1) During fiscal year 2012 and thereafter, the Secretary (as defined in section 1722 of this title) may appoint, without regard to the provisions of subchapter I of chapter 33 of title 5, other than sections 3303 and 3328 of such title, a qualified candidate described in paragraph (2) directly to a position for which the candidate meets Office of Personnel Management qualification standards.

(2) Paragraph (1) applies with respect to a former resource assistant (as defined in section 1722 of this title) who—

(A) completed a rigorous undergraduate or graduate summer internship with the Secretary (as so defined), such as the National Park Service Business Plan Internship;

(B) successfully fulfilled the requirements of the internship program; and

(C) subsequently earned an undergraduate or graduate degree from an accredited institution of higher education.

(3) The direct hire authority under this section may not be exercised with respect to a specific qualified candidate after the end of the two-year period beginning on the date on which the candidate completed the undergraduate or graduate degree, as the case may be.

(Pub. L. 112–74, div. E, title I, §121(a), Dec. 23, 2011, 125 Stat. 1012; Pub. L. 116–9, title IX, §9003(d)(2), Mar. 12, 2019, 133 Stat. 834.)

#### **Editorial Notes**

#### Codification

Section was enacted as part of the Department of the Interior, Environment, and Related Agencies Appropriations Act, 2012, and also as part of the Consolidated Appropriations Act, 2012, and not as part of the Public Lands Corps Act of 1993 which comprises this subchapter.

#### Amendments

2019—Par. (1). Pub. L. 116–9, §9003(d)(2)(A), substituted "Secretary (as defined in section 1722 of this title)" for "Secretary of the Interior" and "paragraph (2)" for "paragraph (1)" and struck out "with a land managing agency of the Department of the Interior" after "position".

Par. (2)(A). Pub. L. 116–9, §9003(d)(2)(B), substituted "with the Secretary (as so defined)" for "with a land managing agency".
[if !vml]>[endif]>

[if !vml]>[endif]>

You have reached the FederalDepository Library Program Electronic Collection (FDLP/EC) Archive. Thisarchive assures ongoing access to publications in the FDLP/EC. Access topublications in the archive is available through GPO's suite of cataloging andlocator services, including the Catalog of U.S. Government Publications(CGP).  Archived copies of publications are retrieved in the event thatpublications are no longer available from the original publishing agency site. 
**Title: Validationof eDNA markers for New Zealand mudsnail surveillance and initial eDNAmonitoring at Mississippi River Basin sites**
 
Report | Table 4 | Table 5 | Table 6 | Table 7
 
SuDoc Number:I 19.76:2015-1037
Item Number:0624-H (online)
CGP systemNumber:000944586
 
June 4, 2018
| 1. | I      have reviewed this Amendment No. 1 to the annual report on Form 10-K of      MFRI, Inc.; and for the year ended January 31,  2010. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | Based      on my knowledge, this report does not contain any untrue statement of a      material fact or omit to state a material fact necessary to make the      statements made, in light of the circumstances under which such statements      were made, not misleading with respect to the period covered by this      report; |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/      David Unger  |   |
|----------------------------|--------|
### §715e. Penalties for violation of chapter

Any person knowingly violating any provision of this chapter or any regulation prescribed thereunder shall upon conviction be punished by a fine of not to exceed $2,000 or by imprisonment for not to exceed six months, or by both such fine and imprisonment.

(Feb. 22, 1935, ch. 18, §6, 49 Stat. 32.)
**EXHIBIT
      32.1**





**CERTIFICATION
      PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**




In
      connection with the Quarterly Report of Whitemark Homes, Inc. (the “ Company ”)
      on
      Form 10-KSB/A for the period ended December 31, 2007 as filed with the U.S.
      Securities and Exchange Commission on the date hereof (the “ Report ”),
      the
      undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted
      pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his
      knowledge:




1.  The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




2.  The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operation of the Company.




Date:  September
      2, 2008





/s/
                Barry ReeseName:
                Barry ReeseTitle:
                Chief Executive Officer, Acting Chief Financial Officer,
              Principal
                Executive Officer and Acting Principal Financial and
              Accounting
                Officer and Director





A
      signed
      original of this written statement required by Section 906, or other document
      authentications, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement required
      by Section 906, has been provided to the Company and will be retained by the
      Company and furnished to the U.S. Securities and Exchange Commission or its
      staff upon request.
# C_2012366EN.01001301.xml

| 24.11.2012 | EN | Official Journal of the European Union | C 366/13 |
| --- | --- | --- | --- |

24.11.2012

EN

Official Journal of the European Union

C 366/13

---

Judgment of the Court (Third Chamber) of 4 October 2012 (reference for a preliminary ruling from the Juzgado de lo Mercantil No 2, A Coruña — Spain) — Germán Rodríguez Cachafeiro, María de los Reyes Martínez-Reboredo Varela-Villamor v Iberia, Líneas Aéreas de España SA

(Case C-321/11) (1)

1

(Air transport - Regulation (EC) No 261/2004 - Compensation for passengers in the event of denied boarding - Concept of ‘denied boarding’ - Cancellation of a passenger’s boarding card by an air carrier because of the anticipated delay to an earlier flight also operated by it which included check-in for the flight concerned)

2012/C 366/21

Language of the case: Spanish

Referring court

Referring court

Juzgado de lo Mercantil No 2, A Coruña

Parties to the main proceedings

Parties to the main proceedings

Applicants: Germán Rodríguez Cachafeiro, María de los Reyes Martínez-Reboredo Varela-Villamor

Applicants:

Defendant: Iberia, Líneas Aéreas de España SA

Defendant:

Re:

Re:

Reference for a preliminary ruling — Juzgado de lo Mercantil No 2 de A Coruña — Interpretation of Articles 2(j), 3(2), 4(3), 5 and 7 of Regulation (EC) No 261/2004 of the European Parliament and of the Council of 11 February 2004 establishing common rules on compensation and assistance to passengers in the event of denied boarding and of cancellation or long delay of flights, and repealing Regulation (EEC) No 295/91 (OJ 2004 L 46, p. 1) — Concept of ‘denied boarding’ — Denial of boarding on a connecting flight because of delay to the first flight attributable to the airline — Allocation of seats on the connecting flight to other passengers because it was envisaged that it would be impossible for the passengers in question to arrive in time to catch their connecting flight, which was not the case

Operative part of the judgment

Operative part of the judgment

Article 2(j) of Regulation (EC) No 261/2004 of the European Parliament and of the Council of 11 February 2004 establishing common rules on compensation and assistance to passengers in the event of denied boarding and of cancellation or long delay of flights, and repealing Regulation (EEC) No 295/91, read in conjunction with Article 3(2) of Regulation No 261/2004, must be interpreted as meaning that the concept of ‘denied boarding’ includes a situation where, in the context of a single contract of carriage involving a number of reservations on immediately connecting flights and a single check-in, an air carrier denies boarding to some passengers on the ground that the first flight included in their reservation has been subject to a delay attributable to that carrier and the latter mistakenly expected those passengers not to arrive in time to board the second flight.

---

(1)  OJ C 282, 24.9.2011.

1

---
HELP YOUR CHILDREN GROW.

Spend time together to show you care about your child’s 

health, wellness, and success.

Young people are more likely to listen when they know you’re on their side. Explain 

why you don’t want your child to drink or use other drugs—not just because you 

say so, but because you want your child to be happy and safe. For tips on how—

and when—to begin the conversation, visit: 

www.underagedrinking.samhsa.gov

SMA-18-5084
| **CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) (USD $)In Thousands, unless otherwise specified** | 6 Months Ended |
|---------------------------------------------------------------------------------------------------------------------------------|----------------|
||
| Underwriting discounts and commissions                                                                                          | $ 2,415        | $ 2,244 |
| Offering expenses                                                                                                               | $ 376          | $ 314 |

| X                                                                                                                                                                                                                                                                                                        |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Offering expenses associated with a common stock offering during the reporting period.
+ References
No definition available.
+ Details**Name:**pgnx_CommonStockOfferingExpenses**Namespace Prefix:**pgnx_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
| X                                                                                                                                                                                                                                                                                                                                                |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| - Definition
Underwriting discounts and commissions associated with a common stock offering during the reporting period.
+ References
No definition available.
+ Details**Name:**pgnx_CommonStockUnderwritingDiscountsAndCommissions**Namespace Prefix:**pgnx_**Data Type:**xbrli:monetaryItemType**Balance Type:**debit**Period Type:**duration |
Exhibit
      32.1





**CERTIFICATION
      PURSUANT TO RULE 13a-14(b) OR**


**RULE
      15d-14(b) and 18 U.S.C. §1350,**


**AS
      ADOPTED
      PURSUANT TO**


**SECTION
      906
      OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with
      the quarterly report of Sharp Holding Corporation (the "Company") on Form 10-QSB
      for the period ended June 30, 2005 as filed with the Securities and Exchange
      Commission on the date hereof (the "Report"), I, George Sharp, Chief Executive
      Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted
      pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1) Based
      on my
      knowledge, the Report fully complies with the requirements of Section 13(a)
      or
      15(d) of the Securities Exchange Act of 1934; and





(2) Based
      on my
      knowledge, the information contained in the Report fairly presents, in all
      material respects, the financial condition and results of operations of the
      Company.





Date:**August
                22, 2005**





**/s/
                George Sharp****George
                Sharp****Chief
                Executive Officer of Sharp Holding
                Corporation**
J. 

EiMM Dal MOBEMIZEEMBEH EMMEINEREMIETIMEIIIII 

claims challenged the conditions of confinement. See Bowen v. Warden, 

100 Nev. 489, 686 P.2d 250 (1984). Accordingly, we 

ORDER the judgment of the district court AFFIRMED. 

Hardesty 

cc: Hon. Gloria Sturman, District Judge 

Michael Gonzalez 

Attorney General/Las Vegas 

Attorney General/Carson City 

Clark County District Attorney 

Eighth District Court Clerk 

SUPREME COURT 

OF 

NEVADA 

(0) I947A 

2
#### §§ 39.161-39.169 [Reserved]
Creation Date Fri Sep 11, 1998  02:45 PM                            Page    1
CMB96A

From: The Chase Manhattan Bank

To:   Norwest Bank Minnesota, N.A.


                   MONTHLY CERTIFICATEHOLDER'S REPORT
                   ----------------------------------

Due Period 31 Beginning Date                     08/01/1998
Due Period 31 End Date                           08/31/1998
Determination Date                               09/10/1998
Remittance Date                                  09/15/1998


I.    Monthly Principal and Principal Carryover Shortfall to Certificateholders
      (Per $1000 of Original Principal Amount)                  $ 16.2320777116

II.   Monthly Interest and Unpaid Interest to Certificateholders
      (Per $1000 of Original Principal Amount)                   $ 1.0420715052

III.  Monthly Expenses Summary

      A. Servicing Fee Disbursement                                $ 295,440.05
      B. Cash Collateral Account Expense                                 $ 0.00
      C. Total Expenses paid
         (per $1000 of Original Principal Amount)                $ 0.2003983664

IV.   Cash Collateral Account Deposit Amount                             $ 0.00

V.    Outstanding Advance Summary

      A. From Prior Period                                       $ 3,852,109.99
      B. From Current Period                                     $ 3,786,292.74
      C. Change in Amount Between Periods (Lines B - A)            $ -65,817.25

VI.   Pool Factor Information

      A. Certificate Principal Balance                         $ 330,597,694.89
      B. Initial Certificate Balance                         $ 1,474,263,764.33
      C. Pool Factor (Lines A / B)                               0.224245961197

VII.  Available Cash Collateral Account Information for Due Period

      A. Available Cash Collateral Amount                       $ 17,726,402.94
      B. Available Cash Collateral Amount Percentage            4.999999998872%

VIII. Required Cash Collateral Amount

      A. For the Current Collection Period                      $ 17,726,402.94
      B. For the Next Collection Period                         $ 16,529,884.74
حافظ على 

هدوئك 

و 

اغسل 

يديك 

CS243041B